These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17548689)

  • 1. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
    Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LTA 252GG and GA genotypes are associated with diffuse-type noncardia gastric cancer risk in the Japanese population.
    Suzuki G; Cullings H; Fujiwara S; Matsuura S; Kishi T; Ohishi W; Akahoshi M; Hayashi T; Tahara E
    Helicobacter; 2009 Dec; 14(6):571-9. PubMed ID: 19889075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Acta Oncol; 2008; 47(3):360-5. PubMed ID: 18347999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults.
    Kikuchi S; Crabtree JE; Forman D; Kurosawa M
    Am J Gastroenterol; 1999 Dec; 94(12):3455-9. PubMed ID: 10606302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between polymorphisms in glutathione S-transferase Mu3 and IgG titer levels in serum against Helicobacter pylori.
    Tatemichi M; Iwasaki M; Sasazuki S; Tsugane S
    J Hum Genet; 2009 Oct; 54(10):557-63. PubMed ID: 19696791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to Helicobacter pylori infection in children with intellectual disabilities.
    Douraghi M; Goudarzi H; Nateghi Rostami M; Nikmanesh B
    Res Dev Disabil; 2012; 33(2):663-9. PubMed ID: 22186633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation between infection of CagA-positive Helicobacter pylori and upper gastrointestinal diseases].
    Yang G; Hu F; Jia J
    Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):648-50. PubMed ID: 11798940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between Helicobacter pylori CagA status and colorectal cancer.
    Shmuely H; Passaro D; Figer A; Niv Y; Pitlik S; Samra Z; Koren R; Yahav J
    Am J Gastroenterol; 2001 Dec; 96(12):3406-10. PubMed ID: 11774957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
    Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH
    Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
    Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori-CagA seropositivity and nitrite and ascorbic acid food intake as predictors for gastric cancer.
    López-Carrillo L; Torres-López J; Galván-Portillo M; Muñoz L; López-Cervantes M
    Eur J Cancer; 2004 Jul; 40(11):1752-9. PubMed ID: 15251166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of IgG antibody titer against Helicobacter pylori.
    Tatemichi M; Sasazuki S; Inoue M; Tsugane S;
    Helicobacter; 2009 Jun; 14(3):231-6. PubMed ID: 19702853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.
    Nomura AM; Kolonel LN; Miki K; Stemmermann GN; Wilkens LR; Goodman MT; Perez-Perez GI; Blaser MJ
    J Infect Dis; 2005 Jun; 191(12):2075-81. PubMed ID: 15897993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs.
    Maeda S; Yoshida H; Ogura K; Yamaji Y; Ikenoue T; Mitsushima T; Tagawa H; Kawaguchi R; Mori K; Mafune Ki; Kawabe T; Shiratori Y; Omata M
    Cancer; 2000 Apr; 88(7):1530-5. PubMed ID: 10738209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Helicobacter pylori CagA(+) infection in gastric cancer patients].
    Ławniczak M; Starzyńska T
    Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between Helicobacter pylori tyrosine-phosphorylated CagA-related markers and the development of diffuse-type gastric cancers: a case-control study.
    Wada Y; Ito M; Takata S; Tanaka S; Yoshihara M; Chayama K
    Digestion; 2010; 82(1):10-7. PubMed ID: 20145403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.